Patch testing with corticosteroid mixes in Europe. A multicentre study of the EECDRG

Contact Dermatitis

Volumn 42, Issue 1, 2000, Pages 27-35

  Isaksson, Marléne ^a   Andersen, K E ^b   Brandao F M ^c   Bruynzeel, D P ^d   Bruze, M ^a   Camarasa, J G ^e   Diepgen, T ^f   Ducombs, G ^g   Frosch, P J ^h   Goossens, A ⁱ   Lahti, A ^j   Menne T ^k   Rycroft, R J G ^l   Seidenari, S ^m   Shaw, S ^p   Tosti, A ⁿ   Wahlberg, J ^o   White, I R ^l   Wilkinson, J D ^p  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^c HOSPITAL GARCIA DE ORTA   (Portugal)

^d VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^e HOSPITAL DEL MAR   (Spain)

^f UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^g HÔPITAL PELLEGRIN   (France)

^h UNIVERSITY OF WITTEN HERDECKE   (Germany)

ⁱ UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^j UNIVERSITY OF OULU   (Finland)

^k GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^l ST THOMAS HOSPITAL   (United Kingdom)

^m UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

ⁿ UNIVERSITY OF BOLOGNA   (Italy)

^o KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^p AMERSHAM HOSPITAL   (United Kingdom)

more..

Author keywords

Budesonide; Contact allergy; Corticosteroids; Hydrocortisone 17 butyrate; Medicaments; Mixes; Patch testing technique; Tixocortol pivalate

Indexed keywords

BUDESONIDE; CORTICOSTEROID; HYDROCORTISONE BUTYRATE; TIXOCORTOL PIVALATE;

ARTICLE; CLINICAL TRIAL; CONTACT ALLERGY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DRUG HYPERSENSITIVITY; DRUG MIXTURE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PATCH TEST;

ADMINISTRATION, TOPICAL; ANTI-INFLAMMATORY AGENTS; BUDESONIDE; DERMATITIS, ALLERGIC CONTACT; DRUG COMBINATIONS; DRUG HYPERSENSITIVITY; FEMALE; HUMANS; HYDROCORTISONE; MALE; PATCH TESTS;

EID: 0033955175     PISSN: 01051873     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0536.2000.042001027.x     Document Type: Article

References (14)

1. 1. Burden A D, Beck M H. Contact hypersensitivity to topical corticosteroids. Br J Derm 1992: 127: 497-500.
2. 2. Lauerma A I. Screening for corticosteroid contact sensitivity. Comparison of tixocortol pivalate, hydrocortisone-17-butyrate and hydrocortisone. Contact Dermatitis 1991: 24: 123-130.
3. 3. Dooms-Goossens A, Morren M. Results of routine patch testing with corticosteroid series in 2073 patients. Contact Dermatitis 1992: 26: 182-191.
4. 4. Wilkinson S M, Cartwright P H, English J S C. Hydrocortisone: an important cutaneous allergen. Lancet 1991: 337: 761-762.
5. 5. Dooms-Goossens A, Meinardi M M H M, Bos J D, Degreef H. Contact allergy to corticosteroids: the results of a two-centre study. Br J Derm 1994: 130: 42-47.
6. 6. Lepoittevin J P, Drieghe J, Dooms-Goossens A. Studies in patients with corticosteroid contact allergy. Understanding cross-reactivity among different steroids. Arch Dermatol 1995: 131: 31-37.
7. 7. Mitchell J C. Patch testing with mixes. Note on mercaptobenzothiazole mix. Contact Dermatitis 1981: 7: 98-104.
8. 8. Fregert S. Manual of contact dermatitis, 2nd edition. Copenhagen: Munksgaard, 1981.
9. 9. Pecegueiro M. Contact allergy to topical corticosteroids: a screening study with a corticosteroid mix. Contact Dermatitis 1995: 33: 196-197.
10. 10. Isaksson M, Bruze M, Goossens A, Lepoittevin J-P. Patch testing with budesonide in serial dilutions: the significance of dose, occlusion time and reading time. Contact Dermatitis 1999: 1: 24-31.
11. 11. Reitamo S, Lauerma A I, Förström L. Detection of contact hypersensitivity to topical corticosteroids with hydrocortisone-17-butyrate. Contact Dermatitis 1989: 21: 159-165.
12. 12. Bruze M, Edman B, Malmkvist-Padoan S, Svensson Å, Björkner B, Möller H. The significance of a second patch test reading after one week. In manuscript form.
13. 13. Le Coz C J, El Bakali A, Untereiner F, Grosshans E. Active sensitization to budesonide and para-phenylenediamine from patch testing. Contact Dermatitis 1997: 39: 153-155.
14. 14. Isaksson M, Bruze M, Björkner B, Hindsén M, Svensson L. The benefit of patch testing with a corticosteroid at a low concentration. Am J Contact Dermatitis 1999: 10: 31-33.